Abiopharma

🔍 Pearson Mark (Director)

Company: Equitable Holdings, Inc. (EQH)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 1,359 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 754,761.41 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.
• F2: Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.